This webcast aims to address the unmet needs of Alopecia Areata, current management of the disease and how Olumiant the first and only approved JAKi for the treatment of AA can help address those needs helping patients move from hiding to thriving
1.The impact that AA has on patients beyond hair loss and the limitations of current therapies
2. The MOA of Olumiant in AA as well as its benefit risk profile and practical use in severe AA
FREE
Free